Targeting of liposomes via PSGL1 for enhanced tumor accumulation.
Targeting of liposomes via PSGL1 for enhanced tumor accumulation.
复制标题
通过 PSGL1 靶向脂质体以增强肿瘤积累。
DOI:
10.1007/s11095-012-0875-5
复制
发表时间:
2013-02
影响因子:
3.7
通讯作者:
Coussios, Constantin C.
中科院分区:
文献类型:
--
作者:
Carlisle, Robert;Seymour, Leonard W.;Coussios, Constantin C.
To improve the delivery of liposomes to tumors using P-selectin glycoprotein ligand 1 (PSGL1) mediated binding to selectin molecules, which are upregulated on tumorassociated endothelium. PSGL1 was orientated and presented on the surface of liposomes to achieve optimal selectin binding using a novel streptavidin-protein G linker molecule. Loading of PSGL1 liposomes with luciferin allowed their binding to e-selectin and activated HUVEC to be quantified in vitro and their stability, pharmacokinetics and tumor accumulation to be tested in vivo using murine models. PSGL1 liposomes showed 5-fold (p < 0.05) greater selectin binding than identically formulated control liposomes modified with ligand that did not contain the selectin binding domain. When added to HUVEC, PSGL1 liposomes showed >7-fold (p < 0.001) greater attachment than control liposomes. In in vivo studies PSGL1 liposomes showed similar stability and circulation to control liposomes but demonstrated a >3-fold enhancement in the level of delivery to tumors (p < 0.05). The technologies and strategies described here may contribute to clinical improvements in the selectivity and efficacy of liposomal drug delivery agents. The online version of this article (doi:10.1007/s11095-012-0875-5) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
5.4
作者:
Korokhov, N;Mikheeva, G;Krasnykh, V
通讯作者:
Krasnykh, V
影响因子:
5.1
作者:
Lievens, J;Snoeys, J;De Geest, B
通讯作者:
De Geest, B
影响因子:
2.3
作者:
Mayer, B;Spatz, H;Schildberg, FW
通讯作者:
Schildberg, FW
影响因子:
10.8
作者:
Deckers, Roel;Moonen, Chrit T. W.
通讯作者:
Moonen, Chrit T. W.
影响因子:
3.5
作者:
Brujan, EA;Ikeda, T;Matsumoto, Y
通讯作者:
Matsumoto, Y